Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

[Increase in NETO2 gene expression is a potential molecular genetic marker in renal and lung cancers].

Oparina NIu, Sadritdinova AF, Snezhkina AV, Dmitriev AA, Krasnov GS, Senchenko VN, Mel'nikova NV, Belenikin MS, Lakunina VA, Veselovskiĭ VA, Stepanov OA, Kudriavtseva AV.

Genetika. 2012 May;48(5):599-607. Russian.

PMID:
22830255
2.

[Expression of FTL and FTH genes encoding ferretin subunits in lung and renal carcinomas].

Kudriavtseva AV, Anedchenko EA, Oparina NIu, Krasnov GS, Kashkin KN, Dmitriev AA, Zborobskaia IB, Kondtrat'eva TT, Vinogradova TV, Zinov'eva MV, Kopantsev EP, Senchenko VN.

Mol Biol (Mosk). 2009 Nov-Dec;43(6):1044-54. Russian. Erratum in: Mol Biol (Mosk). 2010 Mar-Apr;44(2):384. Vinogradova, E V [corrected to Vinogradova, T V].

PMID:
20088381
3.

[Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].

Anedchenko EA, Dmitriev AA, Krasnov GS, Kondrat'eva TT, Kopantsev EP, Vinogradova TV, Zinov'eva MV, Zborovskaia IB, Polotskiĭ BE, Sakharova OV, Kashuba VI, Zabarovskiĭ ER, Senchenko VN.

Mol Biol (Mosk). 2008 Nov-Dec;42(6):965-76. Russian.

PMID:
19140316
4.

[Novel reference gene RPN1 for normalization of quantitative data in lung and kidney cancer].

Krasnov GS, Oparina NIu, Dmitriev AA, Kudriavtsev AV, Anedchenko EA, Kondrat'eva TT, Zabarovskiĭ ER, Senchenko VN.

Mol Biol (Mosk). 2011 Mar-Apr;45(2):238-48. Russian.

PMID:
21634111
5.

Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer.

Ishikawa N, Daigo Y, Takano A, Taniwaki M, Kato T, Tanaka S, Yasui W, Takeshima Y, Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y.

Cancer Sci. 2006 Aug;97(8):737-45.

6.

Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.

Kim B, Lee HJ, Choi HY, Shin Y, Nam S, Seo G, Son DS, Jo J, Kim J, Lee J, Kim J, Kim K, Lee S.

Cancer Res. 2007 Aug 1;67(15):7431-8.

7.

[Alteration of SEMA3B gene expression levels in epithelial tumors].

Pronina IV, Loginov VI, Prasolov VS, Klimov EA, Khodyrev DS, Kazubskaia TP, Gar'kavtseva RF, Sulimova GE, Braga EA.

Mol Biol (Mosk). 2009 May-Jun;43(3):439-45. Russian.

PMID:
19548530
8.

A preliminary transcriptome map of non-small cell lung cancer.

Fujii T, Dracheva T, Player A, Chacko S, Clifford R, Strausberg RL, Buetow K, Azumi N, Travis WD, Jen J.

Cancer Res. 2002 Jun 15;62(12):3340-6.

9.

Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.

Hornsby CD, Cohen C, Amin MB, Picken MM, Lawson D, Yin-Goen Q, Young AN.

Arch Pathol Lab Med. 2007 Oct;131(10):1541-6.

PMID:
17922590
10.

Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.

Yoshimura A, Gemma A, Hosoya Y, Komaki E, Hosomi Y, Okano T, Takenaka K, Matuda K, Seike M, Uematsu K, Hibino S, Shibuya M, Yamada T, Hirohashi S, Kudoh S.

Genes Chromosomes Cancer. 2003 Jun;37(2):159-64.

PMID:
12696064
11.

Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer.

Masuda K, Takano A, Oshita H, Akiyama H, Tsuchiya E, Kohno N, Nakamura Y, Daigo Y.

Clin Cancer Res. 2011 Dec 15;17(24):7712-22. doi: 10.1158/1078-0432.CCR-11-0619. Epub 2011 Oct 20.

13.

Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.

Balamurugan K, Luu VD, Kaufmann MR, Hofmann VS, Boysen G, Barth S, Bordoli MR, Stiehl DP, Moch H, Schraml P, Wenger RH, Camenisch G.

Oncogene. 2009 Sep 17;28(37):3274-85. doi: 10.1038/onc.2009.186. Epub 2009 Jul 6.

PMID:
19581925
14.

HMGA2 overexpression in non-small cell lung cancer.

Meyer B, Loeschke S, Schultze A, Weigel T, Sandkamp M, Goldmann T, Vollmer E, Bullerdiek J.

Mol Carcinog. 2007 Jul;46(7):503-11.

PMID:
17477356
15.

Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?

Tölle A, Jung M, Lein M, Johannsen M, Miller K, Moch H, Jung K, Kristiansen G.

BMC Cancer. 2009 Jul 21;9:248. doi: 10.1186/1471-2407-9-248.

16.

Loss of expression of the DRR 1 gene at chromosomal segment 3p21.1 in renal cell carcinoma.

Wang L, Darling J, Zhang JS, Liu W, Qian J, Bostwick D, Hartmann L, Jenkins R, Bardenhauer W, Schutte J, Opalka B, Smith DI.

Genes Chromosomes Cancer. 2000 Jan;27(1):1-10.

PMID:
10564580
17.

Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.

Miura N, Nakamura H, Sato R, Tsukamoto T, Harada T, Takahashi S, Adachi Y, Shomori K, Sano A, Kishimoto Y, Ito H, Hasegawa J, Shiota G.

Cancer Sci. 2006 Dec;97(12):1366-73.

18.

The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.

Kanou T, Oneyama C, Kawahara K, Okimura A, Ohta M, Ikeda N, Shintani Y, Okumura M, Okada M.

Mol Cancer Res. 2011 Jan;9(1):103-14. doi: 10.1158/1541-7786.MCR-10-0340. Epub 2010 Dec 14.

19.

Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes.

Kuner R, Muley T, Meister M, Ruschhaupt M, Buness A, Xu EC, Schnabel P, Warth A, Poustka A, Sültmann H, Hoffmann H.

Lung Cancer. 2009 Jan;63(1):32-8. doi: 10.1016/j.lungcan.2008.03.033. Epub 2008 May 16.

PMID:
18486272
20.

[Study on the molecular mechanisms of dlk1 stimulated lung cancer cell proliferation].

Liu Y, Tan J, Li L, Li S, Zou S, Zhang Y, Zhang X, Ling B, Han N, Guo S, Gao Y.

Zhongguo Fei Ai Za Zhi. 2010 Oct;13(10):923-7. doi: 10.3779/j.issn.1009-3419.2010.10.12. Chinese. Erratum in: Zhongguo Fei Ai Za Zhi. 2011 May;14(5):440.

Supplemental Content

Support Center